AKAN (AKAN) Stock Price & Analysis
AKAN (AKAN) fell 6.08% to USD 13.76 as of June 10, 2026 at 02:25 UTC, according to Nexqual real-time market data.
AKAN last closed at USD 14.65; the session ranged USD 12.48–14.53 on volume of 37,129 shares. Market capitalization is $7.35M, with a 52-week range of USD 2.3–209.23 (NCM). Source: Nexqual, June 10, 2026 at 02:25 UTC.
Key Statistics (as of June 10, 2026 at 02:25 UTC)
| Price | USD 13.76 |
|---|---|
| Change | ▼ 6.08% (down) |
| Previous Close | USD 14.65 |
| Open | USD 14.23 |
| Day Range | USD 12.48 – 14.53 |
| 52-Week Range | USD 2.3 – 209.23 |
| Volume | 37,129 shares |
| Market Cap | $7.35M |
| Exchange | NCM |
Technical Analysis (AKAN)
Nexqual's technical model rates AKAN "SELL" based on 1 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 02:25 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 46.4 (neutral) |
| vs SMA50 | Below (USD 16.51) |
| MACD | -1.26 (negative) |
Analyst Ratings (AKAN)
Wall Street analysts rate AKAN "None", per Nexqual as of June 10, 2026 at 02:25 UTC.
| Consensus Rating | None |
|---|
Earnings (AKAN)
Source: Nexqual, June 10, 2026 at 02:25 UTC.
Financials & Fundamentals (AKAN)
| Total Revenue | $836,664 |
|---|---|
| Gross Margin | +24.91% |
| Operating Margin | -443.84% |
| Profit Margin | -266.31% |
| ROE | -60.86% |
| Debt / Equity | 11.85 |
| Current Ratio | 1.26 |
| Total Cash | $2.52M |
| Total Debt | $391,241 |
| Free Cash Flow | $-4.87M |
Source: Nexqual, June 10, 2026 at 02:25 UTC.
Financial Health Score (AKAN)
Nexqual rates AKAN's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 02:25 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Strong — $3M cash, no debt |
| Cash Flow | Weak — FCF negative: -$5M, burning cash |
| Efficiency | Critical — ROE -61%, ROA -28.7% |
Ownership (AKAN)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +1.92% |
| Shares Outstanding | 534,418 |
| Float | 32,174 |
| Short % of Float | +14.19% |
Source: Nexqual, June 10, 2026 at 02:25 UTC.
Leadership (AKAN)
AKAN is led by Katharyn Field (age 42), Interim CEO & Executive Director, per Nexqual as of June 10, 2026 at 02:25 UTC.
| Interim CEO & Executive Director | Katharyn Field (age 42) |
|---|---|
| Chief Financial Officer | Gurcharn Deol B.A., M.A. (age 57) |
| VP, COO & Director of First Towers | Francisco Juarez (age 46) |
Major Backers & Investors (AKAN)
Notable institutional backers of AKAN include Continuum Wealth Advisors, LLC , HRT Financial LP, Xtx Topco Ltd, according to Nexqual as of June 10, 2026 at 02:25 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Continuum Wealth Advisors, LLC | 0.71% |
| HRT Financial LP | 0.66% |
| Xtx Topco Ltd | 0.48% |
Source: Nexqual, June 10, 2026 at 02:25 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| VRAX | Virax Biolabs Group Limited | USD 0.19 | ▼ 11.64% |
| GWAV | Greenwave Technology Solutions, | USD 3.46 | ▲ 3.35% |
| SOBR | SOBR Safe, Inc. | USD 0.75 | ▼ 26.86% |
| LUCY | Innovative Eyewear, Inc. | USD 0.9 | ▼ 0.85% |
| SPRC | SciSparc Ltd. | USD 9.31 | ▼ 18.62% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:25 UTC. This page is informational and not investment advice.